Table 3.
Switch to PP6M and dosage.
| n = 200 | n (PP6M administered dose mg) | |
|---|---|---|
| Previous LAI/OAP-Dose mg | ||
| OAP | n = 8 | |
| Olanzapine 15 | 3▸ PP1M 150 | 3 (1000) |
| Quetiapine 300 | 1▸ PP1M 100 | 1 (700) |
| Aripiprazole 15 | 4 ▸PP1M 150 | 4 (1000) |
| PP1M | n = 37 | |
| 100 | 12 | 10 (700), 2 (1000) |
| 150 | 10 | 10 (1000) |
| 200 | 7 | 3 (1000), 4 (1400) |
| 225 | 2 | 1 (1700) 1 (2000) |
| 300 | 6 | 1 (1000), 5 (2000) |
| PP3M | n = 146 | |
| 263 | 8 | 8 (700) |
| 350 | 43 | 40 (700), 3 (1000) |
| 525 | 69 | 61 (1000), 6 (1400), 2 (1700) |
| 740 | 5 | 1 (1000), 3 (1400), 1 (1700) |
| 875 | 5 | 5 (1700) |
| 1050 | 15 | 10 (1700), 5 (2000) |
| 1575 | 1 | 1 (3000) |
| A1M | n = 7 ▸ PP1M 150 | 7 (1000) |
| R-LAI | n = 1 ▸ PP3M 525 | 1 (1000) |
| Z-LAI | n = 1 ▸ PP1M 200 | 1 (1400) |
| Retention rate dose 2 PP6M | 149/158 = 94% | |
A1M, aripiprazole-1-month; LAI, long-acting injectable; OAP, oral antipsychotic; PP1M, paliperidone palmitate 1-month; PP3M, paliperidone palmitate 3-month; PP6M, paliperidone palmitate 6-month; R-LAI, risperidone-LAI; Z-LAI, zuclopentixol-LAI.